BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31483914)

  • 1. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577.
    Yang J; Liang B; Hou S
    J Gene Med; 2019 Nov; 21(11):e3125. PubMed ID: 31483914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA TMPO-AS1 promotes lung adenocarcinoma progression and is negatively regulated by miR-383-5p.
    Mu X; Wu H; Liu J; Hu X; Wu H; Chen L; Liu W; Luo S; Zhao Y
    Biomed Pharmacother; 2020 May; 125():109989. PubMed ID: 32062549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long noncoding RNA TMPO-AS1/miR-126-5p/BRCC3 axis accelerates gastric cancer progression and angiogenesis via activating PI3K/Akt/mTOR pathway.
    Hu Y; Zhang Y; Ding M; Xu R
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1877-1888. PubMed ID: 33295056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA BBOX1-AS1 upregulates HOXC6 expression through miR-361-3p and HuR to drive cervical cancer progression.
    Xu J; Yang B; Wang L; Zhu Y; Zhu X; Xia Z; Zhao Z; Xu L
    Cell Prolif; 2020 Jul; 53(7):e12823. PubMed ID: 32515533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long Noncoding RNA
    Xie F; Xie G; Sun Q
    Cancer Biother Radiopharm; 2020 Mar; 35(2):129-136. PubMed ID: 32077747
    [No Abstract]   [Full Text] [Related]  

  • 6. TMPO-AS1/miR-98-5p/EBF1 feedback loop contributes to the progression of bladder cancer.
    Luo H; Yang L; Liu C; Wang X; Dong Q; Liu L; Wei Q
    Int J Biochem Cell Biol; 2020 May; 122():105702. PubMed ID: 32087328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA TMPO-AS1 serves as a ceRNA to promote osteosarcoma tumorigenesis by regulating miR-199a-5p/WNT7B axis.
    Cui H; Zhao J
    J Cell Biochem; 2020 Mar; 121(3):2284-2293. PubMed ID: 31680323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA TMPO-AS1 accelerates glycolysis by regulating the miR-1270/PKM2 axis in colorectal cancer.
    Jin Y; Jiang A; Sun L; Lu Y
    BMC Cancer; 2024 Feb; 24(1):238. PubMed ID: 38383342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA TMPO-AS1 up-regulates the expression of HIF-1α and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p.
    Peng X; Yan J; Cheng F
    Pathol Res Pract; 2020 Apr; 216(4):152853. PubMed ID: 32139259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA TMPO-AS1 facilitates the progression of colorectal cancer cells via sponging miR-98-5p to upregulate BCAT1 expression.
    Ye J; Yan Y; Xin L; Liu J; Tang T; Bao X
    J Gastroenterol Hepatol; 2022 Jan; 37(1):144-153. PubMed ID: 34370878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TMPO-AS1 Aggravates the Development of Hepatocellular Carcinoma via miR-429/GOT1 Axis.
    Liu X; Shen Z
    Am J Med Sci; 2020 Dec; 360(6):711-720. PubMed ID: 32988599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA TMPO-AS1 promotes progression of non-small cell lung cancer through regulating its natural antisense transcript TMPO.
    Qin Z; Zheng X; Fang Y
    Biochem Biophys Res Commun; 2019 Aug; 516(2):486-493. PubMed ID: 31230752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Role of Thymopoietin-Antisense RNA 1 as Long Noncoding RNA in the Pathogenesis of Human Cancers.
    Zheng Q; Jia J; Zhou Z; Chu Q; Lian W; Chen Z
    DNA Cell Biol; 2021 Jul; 40(7):848-857. PubMed ID: 34096793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA TMPO antisense RNA 1 promotes the malignancy of cholangiocarcinoma cells by regulating let-7g-5p/ high-mobility group A1 axis.
    Chang H; Yao Y
    Bioengineered; 2022 Feb; 13(2):2889-2901. PubMed ID: 35040749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SOX21-AS1 promotes cervical cancer progression by competitively sponging miR-7/VDAC1.
    Zhang X; Zhao X; Li Y; Zhou Y; Zhang Z
    J Cell Physiol; 2019 Aug; 234(10):17494-17504. PubMed ID: 30912129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA TMPO-AS1 facilitates the proliferation and metastasis of NSCLC cells by up-regulating ERBB2 via sponging miR-204-3p.
    Yu X; Lin Q; Liu F; Yang F; Mao J; Chen X
    Int J Immunopathol Pharmacol; 2020; 34():2058738420958947. PubMed ID: 32969763
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
    Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of the long non-coding RNA UNC5B-AS1/miR-4455/RSPO4 axis reduces cervical cancer growth in vitro and in vivo.
    Fu J; Zhang Y; Wang M; Hu J; Fang Y
    J Gene Med; 2021 Dec; 23(12):e3382. PubMed ID: 34350661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA STXBP5-AS1 suppressed cervical cancer progression via targeting miR-96-5p/PTEN axis.
    Shao S; Wang C; Wang S; Zhang H; Zhang Y
    Biomed Pharmacother; 2019 Sep; 117():109082. PubMed ID: 31212131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The LOXL1 antisense RNA 1 (LOXL1-AS1)/microRNA-423-5p (miR-423-5p)/ectodermal-neural cortex 1 (ENC1) axis promotes cervical cancer through the mitogen-activated protein kinase (MEK)/extracellular signal-regulated kinase (ERK) pathway.
    Zhang P; Zhao F; Jia K; Liu X
    Bioengineered; 2022 Feb; 13(2):2567-2584. PubMed ID: 35015607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.